← Back to headlines
Gilead Sciences Exceeds Estimates with 8% Rise in Second-Quarter Sales
Gilead Sciences reported an 8% increase in second-quarter sales, successfully beating Wall Street's financial estimates.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
